BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38268163)

  • 1. Transcription Silencing and CpGs Hypermethylation as Therapeutic Gene Editing in Clinical Colorectal Adenocarcinoma Repression.
    Al-Jumaili MMO
    Korean J Gastroenterol; 2024 Jan; 83(1):6-16. PubMed ID: 38268163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
    Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
    Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of the KEAP1 gene promoter region in human colorectal cancer.
    Hanada N; Takahata T; Zhou Q; Ye X; Sun R; Itoh J; Ishiguro A; Kijima H; Mimura J; Itoh K; Fukuda S; Saijo Y
    BMC Cancer; 2012 Feb; 12():66. PubMed ID: 22325485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation variable position profiles of hMLH1 promoter CpG islands in human sporadic colorectal carcinoma.
    Huang Q; Huang JF; Zhang B; Baum L; Fu WL
    Diagn Mol Pathol; 2012 Mar; 21(1):24-33. PubMed ID: 22306672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation Density Pattern of
    Fabrizio FP; Sparaneo A; Centra F; Trombetta D; Storlazzi CT; Graziano P; Maiello E; Fazio VM; Muscarella LA
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
    Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
    J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma.
    Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Frikha F; Kallel L; Amouri A; Frikha M; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
    Tumour Biol; 2010 Oct; 31(5):503-11. PubMed ID: 20571967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling.
    Hinoue T; Weisenberger DJ; Pan F; Campan M; Kim M; Young J; Whitehall VL; Leggett BA; Laird PW
    PLoS One; 2009 Dec; 4(12):e8357. PubMed ID: 20027224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Methylation in Colorectal Cancer.
    Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P
    Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
    Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
    J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.
    Wang YC; Yu ZH; Liu C; Xu LZ; Yu W; Lu J; Zhu RM; Li GL; Xia XY; Wei XW; Ji HZ; Lu H; Gao Y; Gao WM; Chen LB
    World J Gastroenterol; 2008 May; 14(19):3074-80. PubMed ID: 18494062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of CpG island methylation within divergent and unidirectional promoters in colorectal cancer.
    Namba S; Sato K; Kojima S; Ueno T; Yamamoto Y; Tanaka Y; Inoue S; Nagae G; Iinuma H; Hazama S; Ishihara S; Aburatani H; Mano H; Kawazu M
    Cancer Sci; 2019 Mar; 110(3):1096-1104. PubMed ID: 30637877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.
    Ogino S; Brahmandam M; Kawasaki T; Kirkner GJ; Loda M; Fuchs CS
    Mod Pathol; 2006 Aug; 19(8):1083-90. PubMed ID: 16699497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach.
    Pavicic W; Perkiö E; Kaur S; Peltomäki P
    Mol Med; 2011; 17(7-8):726-35. PubMed ID: 21327300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible gene silencing mechanism: hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells.
    Guo D; Wu B; Yan J; Li X; Sun H; Zhou D
    Biochem Biophys Res Commun; 2012 Nov; 428(1):80-5. PubMed ID: 23047008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer.
    Øster B; Linnet L; Christensen LL; Thorsen K; Ongen H; Dermitzakis ET; Sandoval J; Moran S; Esteller M; Hansen TF; Lamy P; ; Laurberg S; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 May; 132(10):2303-15. PubMed ID: 23115050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer.
    Wong JJ; Hawkins NJ; Ward RL; Hitchins MP
    Mod Pathol; 2011 Mar; 24(3):396-411. PubMed ID: 21102416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.